摘要:

Recently, the clinical focus in antiviral chemotherapy has been on the use of ara-A in herpes infections—HSV encephalitis, zoster in the immunosuppressed, and neonatal herpes. In this last article of a four-part series, the authors review clinical studies that have to date led to the licensing of ara-A for HSV encephalitis but have not yet clearly defined its role in the immunosuppressed or in neonates.

ISSN:2154-8331    

DOI:10.1080/21548331.1981.11946804

出版商:Taylor&Francis    

年代:1981

数据来源: Taylor

ISSN:2154-8331    

DOI:10.1080/21548331.1981.11946805

出版商:Taylor&Francis    

年代:1981

数据来源: Taylor